Hims

Hims publishes its service information, membership FAQ and customer contact channels on its official domain.

Named operator, an attributed physical business address and a working-purpose contact telephone. Distinguish registered or correspondence offices from clinical and dispensing locations; online care does not require a walk-in clinic. Weight: 8%.

The FAQ describes provider review and ongoing support; individual clinician credentials were not checked.

Who the service is for, prescribing or research-use boundaries, and provider information. Weight: 5%.

The FAQ distinguishes introductory and recurring membership charges from medication billed separately.

Public prices or a defined quotation process, with recurring or additional charges explained. Weight: 5%.

Weight-loss terms distinguish membership and medication cancellation. The first membership month is non-refundable, shipped medication is ineligible, and medication-plan refunds depend on stated timing. Support guidance also requires changes before the next charge; no refund request was tested.

Accessible cancellation, refund or ordering terms and a support channel. Weight: 4%.

Terms name six pharmacy businesses. Three have current matching Oklahoma records: XeCare, Apostrophe and CD Pharmacy/Red Rock. Anazao has a closed historical record; exact current legal-entity matches for Anazao, EHT/Curexa and Strive Specialties remain unresolved. Individual prescription assignments were not verified.

Named dispensing partners for care services; analytical documentation or manufacturing information for research businesses. Weight: 10%.

An entity-specific regulatory assessment has not been completed. No clean record or adverse finding is inferred.

Entity/product-specific regulatory notices, enforcement, recalls and their resolution, with dates and jurisdiction. A pharmacy license match alone is not a regulatory-history review. No clean record is inferred from silence. Weight: 10%.

This criterion has not yet been established from the reviewed evidence.

Product- and lot-specific laboratory reports covering molecule identity and purity, with the laboratory, report date and issuer authenticity check. Full credit requires independently established laboratory identity and a traceable verified report. A testing policy or a report for another batch provides limited evidence only; purity does not establish sterility, endotoxin control or treatment safety. Weight: 12%.

This criterion has not yet been established from the reviewed evidence.

An applicable external accreditation, such as LegitScript for healthcare, matched to the exact business or domain in the issuer’s records. A badge alone does not establish current certification. Weight: 3%.

This criterion has not yet been established from the reviewed evidence.

Accessible privacy terms identifying the responsible entities, data uses and applicable health-data notice. A HIPAA claim is not independent verification of compliance; HIPAA is not required of every research business. Weight: 6%.

This criterion has not yet been established from the reviewed evidence.

Specific, dated evidence of relevant security practices or an independently issued audit, with its entity, scope and limits. HTTPS, a marketing seal or a claim of being unhackable is insufficient. Weight: 6%.

This criterion has not yet been established from the reviewed evidence.

Disclosed payment processing, billing authorization and recurring-charge arrangements. No processor brand is preferred and a processor does not certify the provider’s clinical or product quality. Weight: 3%.

This criterion has not yet been established from the reviewed evidence.

Clear product identity and intended use, distinguishing branded medicines, compounded preparations and research materials; presentation and preparation requirements where relevant. A compounded product is not assumed to be an approved generic. Weight: 8%.

This criterion has not yet been established from the reviewed evidence.

Product-specific delivery, temperature and storage instructions, including handling of shipping problems. Refrigeration, freezing or a particular presentation receives no automatic quality bonus. Weight: 5%.

Current Oklahoma records match XeCare 99-10090, Apostrophe 99-9942 and CD Pharmacy/Red Rock 99-9405. AnazaoHealth Corporation 99-7322 is a historical CLOSED record, not evidence that the whole business is closed. Active Curexa/Strive trade-name results have different legal owners from the named Hims partners; those entity matches remain unresolved. State records do not establish every patient prescription.

At least one exactly named dispensing partner matched to an active, unreplaced official state record. This does not verify all partners or all jurisdictions. Weight: 15%.